1 terminated, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Nephrectomy: new trials by email Literature Review of Nephrectomy trials Research Report on Nephrectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas Pembrolizumab Injection [Keytruda], Cryoablation, Nephrectomy - Renal Cell Carcinoma, Metastatic Kidney Cancer | Phase 1 | Withdrawn | University of California, Irvine | 2017-07-01 | 2021-04-05 | |
| Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery Metastasectomy, Nephrectomy, Nivolumab - Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 19 | 2016-05-19 | 2020-10-23 |
Carcinoma, Renal Cell (2) · Kidney Neoplasms (1)
National Cancer Institute (NCI) (1) · University of California, Irvine (1)
United States (2)
Jaime Landman, MD (1) · Martin H Voss (1)
P30CA008748 (1)